CLIA Kit for Insulin (INS)

  • CLIA Kit for Insulin (INS) Packages (Simulation)
  • CLIA Kit for Insulin (INS) Packages (Simulation)
  • CLIA Kit for Insulin (INS) Results demonstration
  • CCA448Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Insulin (INS)

This assay has high sensitivity and excellent specificity for detection of Insulin (INS).
No significant cross-reactivity or interference between Insulin (INS) and analogues was observed.

Recovery of the CLIA Kit for Insulin (INS)

Matrices listed below were spiked with certain level of recombinant Insulin (INS) and the recovery rates were calculated by comparing the measured value to the expected amount of Insulin (INS) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 88-95 92
EDTA plasma(n=5) 88-97 94
heparin plasma(n=5) 80-90 83

Precision of the CLIA Kit for Insulin (INS)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Insulin (INS) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Insulin (INS) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Insulin (INS)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Insulin (INS) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 92-103% 81-99% 78-96% 95-103%
EDTA plasma(n=5) 93-101% 86-103% 80-91% 82-103%
heparin plasma(n=5) 93-101% 82-103% 82-91% 97-105%

Stability of the CLIA Kit for Insulin (INS)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Insulin (INS)

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
7. Read RLU value immediately.

Test principle of the CLIA Kit for Insulin (INS)

The microplate provided in this kit has been pre-coated with a monoclonal antibody specific to Insulin (INS). A competitive inhibition reaction is launched between biotin labeled Insulin (INS) and unlabeled Insulin (INS) (Standards or samples) with the pre-coated antibody specific to Insulin (INS). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Insulin (INS) in the sample. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is reverse proportional to the Insulin (INS) level in the sample or standard.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
NPA448Hu01 Native Insulin (INS) Positive Control; Immunogen; SDS-PAGE; WB.
RPA448Hu01 Recombinant Insulin (INS) Positive Control; Immunogen; SDS-PAGE; WB.
RPA448Hu02 Recombinant Insulin (INS) Positive Control; Immunogen; SDS-PAGE; WB.
PAA448Hu01 Polyclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
PAA448Hu02 Polyclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
LAA448Hu81 FITC-Linked Polyclonal Antibody to Insulin (INS) WB; IHC; ICC; IF.
LAA448Hu71 Biotin-Linked Polyclonal Antibody to Insulin (INS) WB; IHC; ICC.
MAA448Hu21 Monoclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
MAA448Hu23 Monoclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
MAA448Hu24 Monoclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
MAA448Hu25 Monoclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
MAA448Hu27 Monoclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
MAA448Hu22 Monoclonal Antibody to Insulin (INS) WB; IHC; ICC; IP.
CEA448Hu ELISA Kit for Insulin (INS) Enzyme-linked immunosorbent assay for Antigen Detection.
CCA448Hu CLIA Kit for Insulin (INS) Chemiluminescent immunoassay for Antigen Detection.
LMA448Hu Multiplex Assay Kit for Insulin (INS) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK